Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst. #8519
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Long-term follow-up of autotransplant (AT)-supported high-dose melphalan (hdm) for multiple myeloma (MM): update of Intergroup Francophone du Myeloma (IFM), Southwest Oncology Group (SWOG), and Arkansas (ARK) Total Therapy (TT) trials
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst. #8599
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Prognostic factor analyses of myeloma (MM) survival outcomes on intergroup trial S9321 (int 0141): examining whether different variables govern different time segments of survival
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst.#2063
- Year
- 2009
- Research Committee(s)
- Brain
- Study Number(s)
- S9811
Southwest Oncology Group S9811: a phase II study of hydroxyurea for unresectable meningioma
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst.#6607
- Year
- 2009
- Research Committee(s)
- Multiple sites
Does quality of treatment-related harms reporting affect conclusions about superiority of treatment?
- Journal / Conference
- Therapeutic Advances in Medical Oncology 1(2):69-77;
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0032, S0111, S0354, S0418, S0421, SWOG-8219, SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889), SWOG-9346, SWOG-9407, SWOG-9426, S9916
Cooperative group trials - Southwest Oncology Group (SWOG) innovations in advanced prostate cancer [PMID21085622; PMC2981166]
- Journal / Conference
- San Antonio Breast Cancer Symposium, 2009, poster presentation, abst. #2001
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
Variants in the BRCA1/Fanconi-Anemia repair pathway and taxane-induced neuropathy in SWOG directed intergroup study S0221
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 75(3)supl., abst #1094, S168. ASTRO poster discuss.
- Year
- 2009
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0414
Cetuximab (C225) plus cisplatin (CDDP), irinotecan (CPT11) and thoracic radiotherapy (TRT as definitive treatment for locally advanced, clinically unresectable esophageal cancer (EC): a Southwest Oncology Group (SWOG) phase II trial with molecular correlates (S0414)
- Journal / Conference
- Journal of Clinical Oncology 27(18):3014-3019
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0222
SWOG 0222: a phase II study of tirapazamine/cisplatin/etoposide and concurrent thoracic radiotherapy for limited stage small cell lung cancer [PMC2702233; PMID19364954]
- Journal / Conference
- Leukemia 23(10):1913-1919
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Genetic polymorphisms of EPHX1, Gsk3B, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma
- Journal / Conference
- Journal of the American Medical Association 301(22)2349-2361
- Year
- 2009
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8124/25/26